Matsuzaki T - Search Results

1

Phosphorylated smad2 in advanced stage gastric carcinoma.

Shinto O, Yashiro M, Toyokawa T, Nishii T, Kaizaki R, Matsuzaki T, Noda S, Kubo N, Tanaka H, Doi Y, Ohira M, Muguruma K, Sawada T, Hirakawa K. Shinto O, et al. Among authors: matsuzaki t. BMC Cancer. 2010 Nov 26;10:652. doi: 10.1186/1471-2407-10-652. BMC Cancer. 2010. PMID: 21110833 Free PMC article.

2

Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model.

Yashiro M, Shinto O, Nakamura K, Tendo M, Matsuoka T, Matsuzaki T, Kaizaki R, Ohira M, Miwa A, Hirakawa K. Yashiro M, et al. Among authors: matsuzaki t. Br J Cancer. 2009 Oct 6;101(7):1100-6. doi: 10.1038/sj.bjc.6605296. Br J Cancer. 2009. PMID: 19738610 Free PMC article.

3

DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells.

Qiu H, Yashiro M, Shinto O, Matsuzaki T, Hirakawa K. Qiu H, et al. Among authors: matsuzaki t. Cancer Sci. 2009 Jan;100(1):181-8. doi: 10.1111/j.1349-7006.2008.01004.x. Epub 2008 Nov 25. Cancer Sci. 2009. PMID: 19037991 Free PMC article.

4

Expression of ERas oncogene in gastric carcinoma.

Kaizaki R, Yashiro M, Shinto O, Yasuda K, Matsuzaki T, Sawada T, Hirakawa K. Kaizaki R, et al. Among authors: matsuzaki t. Anticancer Res. 2009 Jun;29(6):2189-93. Anticancer Res. 2009. PMID: 19528480 Free article.

5

Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.

Yashiro M, Shinto O, Nakamura K, Tendo M, Matsuoka T, Matsuzaki T, Kaizaki R, Miwa A, Hirakawa K. Yashiro M, et al. Among authors: matsuzaki t. Int J Cancer. 2010 Feb 15;126(4):1004-16. doi: 10.1002/ijc.24763. Int J Cancer. 2010. PMID: 19621385

6

Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer.

Matsuzaki T, Yashiro M, Kaizaki R, Yasuda K, Doi Y, Sawada T, Ohira M, Hirakawa K. Matsuzaki T, et al. Cancer Sci. 2009 Dec;100(12):2402-10. doi: 10.1111/j.1349-7006.2009.01315.x. Epub 2009 Aug 18. Cancer Sci. 2009. PMID: 19764996 Free PMC article.

7

An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells.

Yashiro M, Qiu H, Hasegawa T, Zhang X, Matsuzaki T, Hirakawa K. Yashiro M, et al. Among authors: matsuzaki t. Br J Cancer. 2011 Nov 8;105(10):1522-32. doi: 10.1038/bjc.2011.397. Epub 2011 Oct 13. Br J Cancer. 2011. PMID: 21997136 Free PMC article.

8

A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma.

Yashiro M, Nishii T, Hasegawa T, Matsuzaki T, Morisaki T, Fukuoka T, Hirakawa K. Yashiro M, et al. Among authors: matsuzaki t. Br J Cancer. 2013 Nov 12;109(10):2619-28. doi: 10.1038/bjc.2013.638. Epub 2013 Oct 15. Br J Cancer. 2013. PMID: 24129235 Free PMC article.

9

A novel angiogenesis inhibitor, Ki23057, is useful for preventing the progression of colon cancer and the spreading of cancer cells to the liver.

Sakurai K, Yamada N, Yashiro M, Matsuzaki T, Komatsu M, Ohira M, Miwa A, Hirakawa K. Sakurai K, et al. Among authors: matsuzaki t. Eur J Cancer. 2007 Nov;43(17):2612-20. doi: 10.1016/j.ejca.2007.09.002. Epub 2007 Oct 18. Eur J Cancer. 2007. PMID: 17949968

10

Establishment and characterization of multidrug-resistant gastric cancer cell lines.

Zhang X, Yashiro M, Qiu H, Nishii T, Matsuzaki T, Hirakawa K. Zhang X, et al. Among authors: matsuzaki t. Anticancer Res. 2010 Mar;30(3):915-21. Anticancer Res. 2010. PMID: 20393015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,104 results

Search Page

Filters